Drugs / Intrathecal dexmedetomidine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT07170267 Comparator | Sep 2025 → Mar 2026 overdue | — | Tanta University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Intrathecal dexmedetomidine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07170267 ↗ |
| Route | Intrathecal | “5 µg intrathecal dexmedetomidine diluted in 0.5ml saline” NCT07170267 ↗ |